These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15651044)

  • 1. Small-molecule inhibitors and probes for ubiquitin- and ubiquitin-like-specific proteases.
    Borodovsky A; Ovaa H; Meester WJ; Venanzi ES; Bogyo MS; Hekking BG; Ploegh HL; Kessler BM; Overkleeft HS
    Chembiochem; 2005 Feb; 6(2):287-91. PubMed ID: 15651044
    [No Abstract]   [Full Text] [Related]  

  • 2. DeSUMOylating enzymes--SENPs.
    Drag M; Salvesen GS
    IUBMB Life; 2008 Nov; 60(11):734-42. PubMed ID: 18666185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of DEN1, a deneddylase of the ULP family.
    Gan-Erdene T; Nagamalleswari K; Yin L; Wu K; Pan ZQ; Wilkinson KD
    J Biol Chem; 2003 Aug; 278(31):28892-900. PubMed ID: 12759362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMO-specific proteases: a twist in the tail.
    Hay RT
    Trends Cell Biol; 2007 Aug; 17(8):370-6. PubMed ID: 17768054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of small molecule inhibitors and probes of human SUMO deconjugating proteases.
    Albrow VE; Ponder EL; Fasci D; Békés M; Deu E; Salvesen GS; Bogyo M
    Chem Biol; 2011 Jun; 18(6):722-32. PubMed ID: 21700208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMO protease SENP1 induces isomerization of the scissile peptide bond.
    Shen L; Tatham MH; Dong C; Zagórska A; Naismith JH; Hay RT
    Nat Struct Mol Biol; 2006 Dec; 13(12):1069-77. PubMed ID: 17099698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deubiquitinating PCNA: a downside to DNA damage tolerance.
    Ulrich HD
    Nat Cell Biol; 2006 Apr; 8(4):303-5. PubMed ID: 16607265
    [No Abstract]   [Full Text] [Related]  

  • 8. Structural basis of ubiquitin recognition by the deubiquitinating protease USP2.
    Renatus M; Parrado SG; D'Arcy A; Eidhoff U; Gerhartz B; Hassiepen U; Pierrat B; Riedl R; Vinzenz D; Worpenberg S; Kroemer M
    Structure; 2006 Aug; 14(8):1293-302. PubMed ID: 16905103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The differential modulation of USP activity by internal regulatory domains, interactors and eight ubiquitin chain types.
    Faesen AC; Luna-Vargas MP; Geurink PP; Clerici M; Merkx R; van Dijk WJ; Hameed DS; El Oualid F; Ovaa H; Sixma TK
    Chem Biol; 2011 Dec; 18(12):1550-61. PubMed ID: 22195557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A baker's dozen of ubiquitin.
    Haas AL; Leach CA
    Cell Biochem Biophys; 2011 Jun; 60(1-2):1. PubMed ID: 21544573
    [No Abstract]   [Full Text] [Related]  

  • 11. Vialinin A is a ubiquitin-specific peptidase inhibitor.
    Okada K; Ye YQ; Taniguchi K; Yoshida A; Akiyama T; Yoshioka Y; Onose J; Koshino H; Takahashi S; Yajima A; Abe N; Yajima S
    Bioorg Med Chem Lett; 2013 Aug; 23(15):4328-31. PubMed ID: 23791076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and characterization of SUMO protease activity using a sensitive enzyme-based reporter assay.
    Leach CA; Tian X; Mattern MR; Nicholson B
    Methods Mol Biol; 2009; 497():269-81. PubMed ID: 19107424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonhydrolyzable ubiquitin-isopeptide isosteres as deubiquitinating enzyme probes.
    Shanmugham A; Fish A; Luna-Vargas MP; Faesen AC; El Oualid F; Sixma TK; Ovaa H
    J Am Chem Soc; 2010 Jul; 132(26):8834-5. PubMed ID: 20540574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation.
    Owerbach D; McKay EM; Yeh ET; Gabbay KH; Bohren KM
    Biochem Biophys Res Commun; 2005 Nov; 337(2):517-20. PubMed ID: 16198310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical Tools and Biochemical Assays for SUMO Specific Proteases (SENPs).
    Jia Y; Claessens LA; Vertegaal ACO; Ovaa H
    ACS Chem Biol; 2019 Nov; 14(11):2389-2395. PubMed ID: 31361113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional determinants of the Epstein-Barr virus protease.
    Buisson M; Valette E; Hernandez JF; Baudin F; Ebel C; Morand P; Seigneurin JM; Arlaud GJ; Ruigrok RW
    J Mol Biol; 2001 Aug; 311(1):217-28. PubMed ID: 11469870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Small Molecule Antagonists of the USP5 Zinc Finger Ubiquitin-Binding Domain.
    Mann MK; Franzoni I; de Freitas RF; Tempel W; Houliston S; Smith L; Vedadi M; Arrowsmith CH; Harding RJ; Schapira M
    J Med Chem; 2019 Nov; 62(22):10144-10155. PubMed ID: 31663737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein modification by SUMO.
    Johnson ES
    Annu Rev Biochem; 2004; 73():355-82. PubMed ID: 15189146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping residues of SUMO precursors essential in differential maturation by SUMO-specific protease, SENP1.
    Xu Z; Au SW
    Biochem J; 2005 Mar; 386(Pt 2):325-30. PubMed ID: 15487983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fragment-based method to discover irreversible covalent inhibitors of cysteine proteases.
    Kathman SG; Xu Z; Statsyuk AV
    J Med Chem; 2014 Jun; 57(11):4969-74. PubMed ID: 24870364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.